Chronic myelogenous leukemia, version 1.2015.

  title={Chronic myelogenous leukemia, version 1.2015.},
  author={Susan O'brien and Jerald P Radich and Camille N. Abboud and Mojtaba Akhtari and Jessica K Altman and Ellin Berman and Peter Gardner Curtin and Daniel J. Deangelo and Michael Deininger and Steven Michael Devine and Amir T Fathi and Jason Gotlib and Madan H. Jagasia and Patricia Kropf and Joseph O. Moore and Arnel Pallera and Vishnu V B Reddy and Neil Pravin Shah and B. Douglas Smith and D. Stephen Snyder and Meir Wetzler and Kristina C. Gregory and Hema M Sundar},
  journal={Journal of the National Comprehensive Cancer Network : JNCCN},
  volume={12 11},
Chronic myelogenous leukemia (CML) is usually diagnosed in the chronic phase. Untreated chronic phase CML will eventually progress to advanced phase (accelerated or blast phase) CML. Tyrosine kinase inhibitors (TKIs) have been shown to induce favorable response rates in patients with accelerated and blast phase CML. The addition of TKIs to chemotherapy has also been associated with improved outcomes in patients with blast phase CML. Allogeneic hematopoietic stem cell transplant remains a… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 24 extracted citations

Similar Papers

Loading similar papers…